The banning of a senior King Pharmaceuticals executive over competition abuses in the supply of an antidepressant brings the UK antitrust regulator’s total director disqualifications to 13 and reflects its continuing appetite to target company bosses.The Competition and Markets Authority today fined four drugmakers a total of 3.4 million pounds ($4.3 million) after